The interaction of genetics and physical activity in the pathogenesis of metabolic dysfunction associated liver disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
01 Aug 2024
Historique:
received: 12 04 2024
accepted: 22 07 2024
medline: 2 8 2024
pubmed: 2 8 2024
entrez: 1 8 2024
Statut: epublish

Résumé

Genetic variants associated with increased liver fat and volume have been reported, but whether physical activity (PA) can attenuate the impact of genetic susceptibility to these traits is poorly understood. We aimed to investigate whether higher PA modify genetic impact on liver-related traits in the UK Biobank cohort. PA was self-reported, while magnetic resonance images were used to estimate liver fat (n = 27,243) and liver volume (n = 24,752). Metabolic dysfunction-associated liver disease (MASLD) and chronic liver disease (CLD) were diagnosed using ICD-9 and ICD-10 codes. Ten liver fat and eleven liver volume-associated genetic variants were selected and unweighted genetic-risk scores for liver fat (GRS

Identifiants

pubmed: 39090170
doi: 10.1038/s41598-024-68271-4
pii: 10.1038/s41598-024-68271-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17817

Subventions

Organisme : European Research Council
ID : GUTSY - 801965
Pays : International
Organisme : Vetenskapsrådet
ID : 2015-03477
Organisme : Vetenskapsrådet
ID : 2018-02784
Organisme : Vetenskapsrådet
ID : 2019-04756
Organisme : Vetenskapsrådet
ID : 2016-01040
Organisme : Vetenskapsrådet
ID : 2022-01460
Organisme : Swedish Heart-Lung Foundation
ID : 20200500
Organisme : Swedish Heart-Lung Foundation
ID : 20220129
Organisme : Swedish Cancer Foundation
ID : 21 0456 FE
Organisme : FORMAS
ID : 2020-00989

Informations de copyright

© 2024. The Author(s).

Références

Byrne, C. D. & Targher, G. NAFLD: A multisystem disease. J. Hepatol. 62(1 Suppl), S47-64 (2015).
doi: 10.1016/j.jhep.2014.12.012 pubmed: 25920090
Mundi, M. S. et al. Evolution of NAFLD and its management. Nutr. Clin. Pract. 35(1), 72–84 (2020).
doi: 10.1002/ncp.10449 pubmed: 31840865
Younossi, Z. et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 69(6), 2672–2682 (2019).
doi: 10.1002/hep.30251 pubmed: 30179269
Bian, H. et al. Impact of non-alcoholic fatty liver disease on liver volume in humans. Hepatol. Res. 45(2), 210–219 (2015).
doi: 10.1111/hepr.12338 pubmed: 24698021
Liu, Y. et al. Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning. Elife https://doi.org/10.7554/eLife.65554 (2021).
doi: 10.7554/eLife.65554 pubmed: 34939931 pmcid: 8763402
Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am. J. Gastroenterol. 107(6), 811–826 (2012).
doi: 10.1038/ajg.2012.128 pubmed: 22641309
Speliotes, E. K. et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7(3), e1001324 (2011).
doi: 10.1371/journal.pgen.1001324 pubmed: 21423719 pmcid: 3053321
Parisinos, C. A. et al. Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis. J. Hepatol. 73(2), 241–251 (2020).
doi: 10.1016/j.jhep.2020.03.032 pubmed: 32247823 pmcid: 7372222
Anstee, Q. M. et al. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆. J. Hepatol. 73(3), 505–515 (2020).
doi: 10.1016/j.jhep.2020.04.003 pubmed: 32298765
van der Windt, D. J., Sud, V., Zhang, H., Tsung, A. & Huang, H. The Effects of physical exercise on fatty liver disease. Gene Expr. 18(2), 89–101 (2018).
doi: 10.3727/105221617X15124844266408 pubmed: 29212576 pmcid: 5954622
Keating, S. E., Hackett, D. A., George, J. & Johnson, N. A. Exercise and non-alcoholic fatty liver disease: A systematic review and meta-analysis. J. Hepatol. 57(1), 157–166 (2012).
doi: 10.1016/j.jhep.2012.02.023 pubmed: 22414768
Ryu, S. et al. Relationship of sitting time and physical activity with non-alcoholic fatty liver disease. J. Hepatol. 63(5), 1229–1237 (2015).
doi: 10.1016/j.jhep.2015.07.010 pubmed: 26385766
Perseghin, G. et al. Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes Care 30(3), 683–688 (2007).
doi: 10.2337/dc06-2032 pubmed: 17327341
Oh, S. et al. Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: A retrospective study. Hepatology 61(4), 1205–1215 (2015).
doi: 10.1002/hep.27544 pubmed: 25271091
Schnurr, T. M. et al. Interactions of physical activity, muscular fitness, adiposity, and genetic risk for NAFLD. Hepatol. Commun. https://doi.org/10.1002/hep4.1932 (2022).
doi: 10.1002/hep4.1932 pubmed: 35293152 pmcid: 9234625
Ge, X. et al. Behavioural activity pattern, genetic factors, and the risk of nonalcoholic fatty liver disease: A prospective study in the <scp>UK</scp> Biobank. Liver Int. 43(6), 1287–1297 (2023).
doi: 10.1111/liv.15588 pubmed: 37088982
Castera, L., Friedrich-Rust, M. & Loomba, R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology 156(5), 1264-1281.e4 (2019).
doi: 10.1053/j.gastro.2018.12.036 pubmed: 30660725
Sudlow, C. et al. UK biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12(3), e1001779 (2015).
doi: 10.1371/journal.pmed.1001779 pubmed: 25826379 pmcid: 4380465
Langner, T., Strand, R., Ahlström, H. & Kullberg, J. Large-Scale Inference of Liver Fat with Neural Networks on UK Biobank Body MRI 602–11 (Springer International Publishing, 2020).
Langner, T. et al. Kidney segmentation in neck-to-knee body MRI of 40,000 UK Biobank participants. Sci. Rep. 10(1), 20963 (2020).
doi: 10.1038/s41598-020-77981-4 pubmed: 33262432 pmcid: 7708493
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 562(7726), 203–209 (2018).
doi: 10.1038/s41586-018-0579-z pubmed: 30305743 pmcid: 6786975
Martin, S. et al. Estimating the effect of liver and pancreas volume and fat content on risk of diabetes: A Mendelian randomization study. Diabetes Care 45(2), 460–468 (2022).
doi: 10.2337/dc21-1262 pubmed: 34983059
Ahmad, S. et al. Gene × physical activity interactions in obesity: Combined analysis of 111,421 individuals of European ancestry. PLoS Genet. 9(7), e1003607 (2013).
doi: 10.1371/journal.pgen.1003607 pubmed: 23935507 pmcid: 3723486
M. Sjostrom, B Ainsworth, A. Bauman, F. Bull, C. Hamilton-Craig, J. Sallis, et al. Guidelines for data processing analysis of the International Physical Activity Questionnaire (IPAQ)-short and long forms. CiNii Articles. (2005).
Censin, J. C. et al. Causal relationships between obesity and the leading causes of death in women and men. PLoS Genet. 15(10), e1008405 (2019).
doi: 10.1371/journal.pgen.1008405 pubmed: 31647808 pmcid: 6812754
VanderWeele, T. J. & Knol, M. J. A tutorial on interaction. Epidemiol. Methods https://doi.org/10.1515/em-2013-0005 (2014).
doi: 10.1515/em-2013-0005 pubmed: 25580377 pmcid: 4287269
Serper, M. et al. Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program. PLoS One 15(8), e0237430 (2020).
doi: 10.1371/journal.pone.0237430 pubmed: 32841307 pmcid: 7447043
Ma, X. et al. Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: A systematic review and meta-analysis. BMC Gastroenterol. 20(1), 10 (2020).
doi: 10.1186/s12876-020-1165-z pubmed: 31937252 pmcid: 6961232
Noureddin, M. et al. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 58(6), 1930–1940 (2013).
doi: 10.1002/hep.26455 pubmed: 23696515
Permutt, Z. et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease—MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol. Ther. 36(1), 22–29 (2012).
doi: 10.1111/j.1365-2036.2012.05121.x pubmed: 22554256 pmcid: 3437221
Brayne, C. & Moffitt, T. E. The limitations of large-scale volunteer databases to address inequalities and global challenges in health and aging. Nat. Aging 2(9), 775–783 (2022).
doi: 10.1038/s43587-022-00277-x pubmed: 37118500 pmcid: 10154032
Murcray, C. E., Lewinger, J. P., Conti, D. V., Thomas, D. C. & Gauderman, W. J. Sample size requirements to detect gene-environment interactions in genome-wide association studies. Genet. Epidemiol. 35(3), 201–210 (2011).
doi: 10.1002/gepi.20569 pubmed: 21308767 pmcid: 3076801
Aschard, H. et al. Challenges and opportunities in genome-wide environmental interaction (GWEI) studies. Hum. Genet. 131(10), 1591–1613 (2012).
doi: 10.1007/s00439-012-1192-0 pubmed: 22760307 pmcid: 3677711
Chen, L. et al. Risk/benefit tradeoff of habitual physical activity and air pollution on chronic pulmonary obstructive disease: Findings from a large prospective cohort study. BMC Med. 20(1), 70 (2022).
doi: 10.1186/s12916-022-02274-8 pubmed: 35220974 pmcid: 8883705
Liu, Q. et al. TRIB1 rs17321515 gene polymorphism increases the risk of coronary heart disease in general population and non-alcoholic fatty liver disease patients in Chinese Han population. Lipids Health Dis. 18(1), 165 (2019).
doi: 10.1186/s12944-019-1108-2 pubmed: 31470861 pmcid: 6717352
Wojcik, G. L. et al. Genetic analyses of diverse populations improves discovery for complex traits. Nature 570(7762), 514–518 (2019).
doi: 10.1038/s41586-019-1310-4 pubmed: 31217584 pmcid: 6785182
Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40(12), 1461–1465 (2008).
doi: 10.1038/ng.257 pubmed: 18820647 pmcid: 2597056
Kozlitina, J. et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 46(4), 352–356 (2014).
doi: 10.1038/ng.2901 pubmed: 24531328 pmcid: 3969786
Kawaguchi, T. et al. Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers. PLoS One 13(1), e0185490 (2018).
doi: 10.1371/journal.pone.0185490 pubmed: 29385134 pmcid: 5791941
Sember, V. et al. Validity and reliability of international physical activity questionnaires for adults across EU countries: Systematic review and meta analysis. Int. J. Environ. Res. Public Health 17(19), 7161 (2020).
doi: 10.3390/ijerph17197161 pubmed: 33007880 pmcid: 7579664
Helmerhorst, H. J. F., Brage, S., Warren, J., Besson, H. & Ekelund, U. A systematic review of reliability and objective criterion-related validity of physical activity questionnaires. Int. J. Behav. Nutr. Phys. Act. 9, 103 (2012).
doi: 10.1186/1479-5868-9-103 pubmed: 22938557 pmcid: 3492158

Auteurs

Hanna Frostdahl (H)

Molecular Epidemiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Nouman Ahmad (N)

Radiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Ulf Hammar (U)

Molecular Epidemiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Andrés Martínez Mora (AM)

Radiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Taro Langner (T)

Radiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Antaros Medical AB, BioVenture Hub, Mölndal, Sweden.

Tove Fall (T)

Molecular Epidemiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Joel Kullberg (J)

Radiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Antaros Medical AB, BioVenture Hub, Mölndal, Sweden.

Håkan Ahlström (H)

Radiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Antaros Medical AB, BioVenture Hub, Mölndal, Sweden.

Hannah L Brooke (HL)

Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Shafqat Ahmad (S)

Molecular Epidemiology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden. shafqat.ahmad@medsci.uu.se.
Preventive Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. shafqat.ahmad@medsci.uu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH